Asset
Vepdegestrant
Rigel Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 219835 | NDA | RIGEL PHARMACEUTICALS INC |
Marketed products (2)
- VEPPANU
- VEPPANU